Clinical Trial Update: Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cardiovascular risk markers and statin response after Kawasaki disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kawasaki Disease

Snippet

Sponsor: Pontificia Universidad Catolica de Chile | Conditions: Kawasaki Disease | Phase 2 | Status: WITHDRAWN